Kimberly-Clark Sees FY Adjusted EPS Between $6.05 And $6.25.
KIMBERLY-CLARK ANNOUNCES THIRD QUARTER 2021 RESULTS.
SEES FY ADJUSTED EARNINGS PER SHARE $6.05 TO $6.25.
Q3 ADJUSTED EARNINGS PER SHARE $1.62.
Q3 EARNINGS PER SHARE $1.39.
Q3 SALES ROSE 7 PERCENT TO $5.0 BILLION.
NOW TARGETING FULL-YEAR 2021 ORGANIC SALES DECLINE OF 1 TO 2 PERCENT AND ADJUSTED EARNINGS PER SHARE OF $6.05 TO $6.25.
PERSONAL CARE SEGMENT Q3 SALES OF $2.7 BILLION INCREASED 14 PERCENT.
UPDATED EARNINGS OUTLOOK REFLECTS SIGNIFICANTLY HIGHER INPUT COST INFLATION.
CONSUMER TISSUE SEGMENT Q3 SALES OF $1.5 BILLION DECREASED 5 PERCENT.
IN QUARTER CHANGES IN FOREIGN CURRENCY EXCHANGE RATES INCREASED SALES 1 PERCENT.
NOW PLANS FOR FULL-YEAR REPURCHASES OF APPROXIMATELY $400 MILLION, AT LOW END OF PREVIOUS RANGE OF $400 TO $450 MILLION.
KIMBERLY-CLARK - QTRLY EARNINGS NEGATIVELY IMPACTED BY SIGNIFICANT INFLATION & SUPPLY CHAIN DISRUPTIONS THAT INCREASED COSTS BEYOND WHAT WE ANTICIPATED.
TAKING FURTHER ACTION, INCLUDING ADDITIONAL PRICING AND ENHANCED COST MANAGEMENT, TO MITIGATE HEADWINDS.
FOR FY 2021 ADJUSTED OPERATING PROFIT EXPECTED TO DECLINE 20 TO 22 PERCENT YEAR-ON-YEAR.
SEES 2021 KEY COST INPUTS EXPECTED TO INCREASE $1,400 TO $1,500 MILLION.
FOR FY 2021 SEES CAPITAL SPENDING OF $1,000 TO $1,100 MILLION.
SEES FY NET SALES INCREASE 1 TO 2 PERCENT.
